Combination Chemotherapy in Treating Patients With Advanced Cancer
Status:
Completed
Trial end date:
2002-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining more than one drug may kill more cancer cells.
PURPOSE: Phase I trial to study the effectiveness of combining R115777 with gemcitabine in
treating patients with advanced cancer.
Phase:
Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio